SURAKSHA DIAGNOSTIC Financial Statement Analysis
|
||
|
The Revenues of SURAKSHA DIAGNOSTIC have increased by 15.03% YoY .
The Earnings Per Share (EPS) of SURAKSHA DIAGNOSTIC has increased by 262.61 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SURAKSHA DIAGNOSTIC Last 5 Annual Financial Results
[BOM: 544293|NSE : SURAKSHA]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Operating Income | ₹219 Cr | ₹190 Cr | ₹223 Cr | ₹140 Cr | ₹157 Cr |
| Expenses | ₹148 Cr | ₹146 Cr | ₹175 Cr | ₹117 Cr | ₹123 Cr |
| Operating Profit (Excl OI) | ₹71 Cr | ₹44 Cr | ₹48 Cr | ₹23 Cr | ₹34 Cr |
| Other Income | ₹3.55 Cr | ₹3.55 Cr | ₹2.30 Cr | ₹1.38 Cr | ₹1.54 Cr |
| Interest | ₹9.61 Cr | ₹9.56 Cr | ₹2.10 Cr | ₹1.90 Cr | ₹2.03 Cr |
| Depreciation | ₹33 Cr | ₹32 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr |
| Profit Before Tax | ₹31 Cr | ₹6.75 Cr | ₹33 Cr | ₹6.37 Cr | ₹21 Cr |
| Profit After Tax | ₹23 Cr | ₹6.07 Cr | ₹24 Cr | ₹6.44 Cr | ₹15 Cr |
| Consolidated Net Profit | ₹24 Cr | ₹6.52 Cr | ₹24 Cr | ₹6.44 Cr | ₹15 Cr |
| Earnings Per Share (Rs) | ₹342.41 | ₹94.43 | ₹344.20 | ₹93.26 | ₹220.48 |
| PAT Margin (%) | 10.57 | 3.19 | 10.64 | 4.60 | 9.66 |
| ROE(%) | 13.93 | 4.01 | 17.40 | 5.30 | 17.73 |
| ROCE(%) | 22.94 | 9.62 | 22.65 | 6.04 | 20.19 |
| Total Debt/Equity(x) | 0.05 | 0.09 | 0.13 | 0.13 | 0.10 |
Key Financials |
||
| Market Cap | : | ₹ 1,558.1 Cr |
| Revenue (TTM) | : | ₹ 238.1 Cr |
| Net Profit(TTM) | : | ₹ 29.0 Cr |
| EPS (TTM) | : | ₹ 5.6 |
| P/E (TTM) | : | 53.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SURAKSHA DIAGNOSTIC | -3.8% | 12.7% | NA |
| MAX HEALTHCARE INSTITUTE | -1% | -2.4% | 37.9% |
| APOLLO HOSPITALS ENTERPRISE | -2.8% | 6.8% | 9.5% |
| FORTIS HEALTHCARE | 2.8% | 6.4% | 50.6% |
| GLOBAL HEALTH | -3.5% | -1.9% | -18.2% |
| NARAYANA HRUDAYALAYA | -2.1% | 7.9% | 40.2% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -1.5% | 7.2% | 67.3% |
| DR LAL PATHLABS | -0.8% | 13.1% | 19.1% |
| ASTER DM HEALTHCARE | -1% | 14.9% | 39.7% |
SURAKSHA DIAGNOSTIC Revenues
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 15.03 % |
| 5 Yr CAGR | 8.55 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹219 Cr | 15.03 | |
| Mar2023 | ₹190 Cr | -14.81 | |
| Mar2022 | ₹223 Cr | 59.42 | |
| Mar2021 | ₹140 Cr | -11.11 | |
| Mar2020 | ₹157 Cr | - | |
SURAKSHA DIAGNOSTIC Operating Profit
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 59.56 % |
| 5 Yr CAGR | 20.07 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹71 Cr | 59.56 | |
| Mar2023 | ₹44 Cr | -7.61 | |
| Mar2022 | ₹48 Cr | 112.64 | |
| Mar2021 | ₹23 Cr | -33.69 | |
| Mar2020 | ₹34 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 38.68 % |
| 5 Yr CAGR | 10.61 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 32.41% | 38.68 | |
| Mar2023 | 23.37% | 8.50 | |
| Mar2022 | 21.54% | 33.37 | |
| Mar2021 | 16.15% | -25.40 | |
| Mar2020 | 21.65% | - | |
SURAKSHA DIAGNOSTIC Profit After Tax
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 262.58 % |
| 5 Yr CAGR | 11.63 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹24 Cr | 262.58 | |
| Mar2023 | ₹6.52 Cr | -72.56 | |
| Mar2022 | ₹24 Cr | 269.08 | |
| Mar2021 | ₹6.44 Cr | -57.70 | |
| Mar2020 | ₹15 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 231.35 % |
| 5 Yr CAGR | 2.28 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 10.57 % | 231.35 | |
| Mar2023 | 3.19 % | -70.02 | |
| Mar2022 | 10.64 % | 131.30 | |
| Mar2021 | 4.6 % | -52.38 | |
| Mar2020 | 9.66 % | - | |
SURAKSHA DIAGNOSTIC Earnings Per Share (EPS)
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 262.61 % |
| 5 Yr CAGR | 11.63 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹342 | 262.61 | |
| Mar2023 | ₹94 | -72.57 | |
| Mar2022 | ₹344 | 269.08 | |
| Mar2021 | ₹93 | -57.70 | |
| Mar2020 | ₹220 | - | |
SURAKSHA DIAGNOSTIC Return on Capital Employed (ROCE)
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 138.46 % |
| 5 Yr CAGR | 3.24 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 22.94% | 138.46 | |
| Mar2023 | 9.62% | -57.53 | |
| Mar2022 | 22.65% | 275.00 | |
| Mar2021 | 6.04% | -70.08 | |
| Mar2020 | 20.19% | - | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Current Share Price | : | ₹299.1 |
| Current MarketCap | : | ₹ 1,558.1 Cr |
| Updated EOD on | : | Apr 30,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SURAKSHA DIAGNOSTIC | -3.8% |
12.7% |
|
| SENSEX | 0.2% |
2.9% |
8.7% |
SURAKSHA DIAGNOSTIC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | -1.1% | 0.5% | 20.8% |
| BSE SMALLCAP | -3.8% | 0.7% | 1.2% |
| BSE IPO | -4.4% | -0.1% | -5.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY IPO INDEX | -3.9% | -0.1% | NA |
You may also like the below Video Courses
FAQ about SURAKSHA DIAGNOSTIC Financials
How the annual revenues of SURAKSHA DIAGNOSTIC have changed ?
The Revenues of SURAKSHA DIAGNOSTIC have increased by 15.03% YoY .
How the Earnings per Share (EPS) of SURAKSHA DIAGNOSTIC have changed?
The Earnings Per Share (EPS) of SURAKSHA DIAGNOSTIC has increased by 262.61 % YoY .
Check out Intrinsic Value of Peers of SURAKSHA DIAGNOSTIC
Compare Stock Analytics of Peers of SURAKSHA DIAGNOSTIC
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
